Navigation Links
ChanTest CEO named Distinguished Service Award recipient by the Safety Pharmacology Society

CLEVELAND, July 24, 2013 /PRNewswire/ -- ChanTest proudly announces that CEO, President and Founder, Arthur "Buzz" Brown, M.D., Ph.D. has been named the recipient of the prestigious Distinguished Service Award by the Safety Pharmacology Society (SPS).  The following statement was issued by the SPS, "The award is in recognition of Dr. Brown's significant scientific contributions to many areas of Safety Pharmacology, most notably contributions to ion channels and their relationship to human disease."

(Photo: )

The SPS will officially present the award at the 13th SPS Annual Meeting in Rotterdam, The Netherlands.  As part of the ceremony, Dr. Brown will present a talk entitled, "Predicting Cardiac Safety: From Molecules to Man" on Thursday, September 19, 2013 from 11:30–12:00 at the Congress Centre de Doelen in Rotterdam.

Dr. Brown's establishment of ChanTest in 1998 allowed pharma and biotech companies to outsource important and unique safety pharmacology studies that have proven difficult and costly to implement "in-house".  To this date, Dr. Brown's lab team at ChanTest continues to provide cutting edge assays that serve the Safety Pharmacology industry.

Dr. Brown collaborates with the US Federal Drug Administration (FDA) on cardiac safety issues and he holds nine patents on ion channel pharmacology, therapeutics and devices.

"I am honored to receive this award," said Dr. Brown.  "The Safety Pharmacology Society has played a key role in the making of better and safer medicines by the pharmaceutical industry." 

For more details about Dr. Brown's career, click here.

About ChanTest – The Ion Channel Expert
ChanTest's mission is to serve the drug discovery and development needs of customers worldwide with high-value solutions for ion channel and GPCR biology. Since its inception in 1998, the company has tested compounds for more than 300 global pharmaceutical and biotechnology companies and partners with them to speed the drug development process for the release of better, safer drugs. ChanTest offers integrated ion channel and GPCR services (GLP and non-GLP) and reagents; the company's library of validated ion channel cell lines and pre-clinical cardiac risk assessment service portfolio are the most comprehensive commercially available today. Because of ChanTest's seminal role in the nonclinical cardiac safety field, along with the company's uncompromising commitment to quality, ChanTest has been named the "most trusted and most used fee-for-service provider" for ion channel screening in independent surveys since 2006. ChanTest is based in Cleveland, Ohio. For more information, e-mail


SOURCE ChanTest Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
2. ChanTest hires Chris Mathes as Chief Commercial Officer
3. Roger Graham Named President of Mylan Specialty
4. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
5. Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS
6. Baby Eva Named After Pioneering IVF Test
7. Comprehensive Care Corporation CEO Clark A. Marcus Named to Board of Americas Agenda: Health Care for All
8. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
9. Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year
10. RenovoRx Named Winner of 2013 TiE50 "Top Startup"
11. Wyle Aided System Gets Named to Space Technology Hall of Fame
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 Research and Markets ... "Membranes Market - Global Forecast to 2020" ... , accounting for 37.21% of the total market ... Asia-Pacific region is projected to growth at ... has been attributed primarily to the fast growing water, ...
(Date:11/24/2015)... SHANGHAI , Nov. 25, 2015 WuXi ... WX ), a leading open-access R&D capability and technology ... industries with operations in China ... announced that at an extraordinary general meeting of shareholders ... the proposal to authorize and approve the previously announced ...
(Date:11/24/2015)... Nov. 24, 2015  In the pharmaceutical industry, companies ... effort to quickly uncover new insights, tactics and strategies ... --> --> However, organizations often find ... project and ensure that all rules and regulations are ... Another major barrier to efficiently launching market research projects ...
Breaking Medicine Technology:
(Date:11/25/2015)... Chicago, IL (PRWEB) , ... November 25, 2015 , ... ... the assets of Tri Lite’s personal heating products business. Cozy Products explains ... low-wattage personal heaters that fit in well with the Cozy Products business model: to ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s ... learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions ... 65 years, Brillianteen has been a treasured tradition for numerous families in the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... scholarships for people struggling with eating disorders as a result of the $20,000 ... annual event, held at Fox Run Golf Club in Eureka, will help individuals ...
(Date:11/25/2015)... ... November 25, 2015 , ... An ... is resulting in a way for homeless people to have a more dignified ... a new initiative whereby they are repurposing plastic bags into sleeping mats for ...
(Date:11/25/2015)... ... , ... Students and parents have something to be thankful for this Thanksgiving ... awards. California Casualty is proud to support the contest designed to utilize ... driving, the number one killer of young drivers. , Almost 1,000 entries of ...
Breaking Medicine News(10 mins):